Revance Therapeutics, Inc


Updates from The Motley Fool

Latest updates on Revance Therapeutics from Fool.com.


Stock Performance

RVNC vs. S&P 500 | 2 Year Performance
View Interactive RVNC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Revance Therapeutics.
Current Price: $14.05
Prev Close: $14.24
Open: $14.06
Bid: $6.12
Ask: $14.70
Day's Range: $13.67 - $14.54
52wk Range: $12.54 - $42.41
Volume: 174,751
Avg Vol 192,174
Market Cap: $394.27M
P/E (ttm): -4.40
EPS (ttm): -$3.24
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Revance Therapeutics.
CAPS Rating 3 out of 5
 
16 Outperform
2 Underperform
CAPS All Stars
 
5 Outperform
2 Underperform

How do you think Revance Therapeutics will perform against the market?



You pick for Revance Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Revance Therapeutics.

Revance Therapeutics, Inc

  • Exchange: NASDAQ